Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
Use Cases
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Loading

Top 30 startups announced for VivaTech 2025 Innovation of the Year

From TechCrunch

By Cindy Zackney

May 29, 2025

Top 30 startups announced for VivaTech 2025 Innovation of the Year

Top 30 startups announced for VivaTech 2025 Innovation of the Year

The Innovation of the Year celebrates the boldest and most visionary startups exhibiting at VivaTech 2025. Open to all exhibiting startups, the award honors those pushing boundaries and redefining industries. Startups were scored on Innovation & Creativity, Market Disruption, and Scalability. From hundreds of applicants, 30 made the short list.

The top five will pitch live at VivaTech on June 11, and the winner will be revealed at the VivaTech Global Awards Ceremony on June 12. The prize? A pitch slot at the ceremony, a free Startup Corner at VivaTech 2026, and a coveted spot in the TechCrunch Startup Battlefield 200. This award recognizes not just great ideas, but also the teams turning bold visions into game-changing realities.

This year’s applicants blew us away. From turning glasses into self-driving guide dogs, to building photonic chips that could redefine computing, to converting mining waste into carbon sinks — this short list is full of breakthrough thinking with real-world stakes. We saw microrobot swarms for space exploration, AI that reads your mind to control devices, and bioelectronic implants fighting brain cancer.

These startups are pushing science, design, and engineering to new heights, especially in areas like sustainability, human-machine interfaces, advanced diagnostics, and accessible healthcare. What stood out most was the boldness. These teams aren’t just solving problems — they’re building the future from the ground up. Choosing five finalists — let alone one winner — will be incredibly tough. Every startup in this top 30 has already earned serious bragging rights.

Here are the VivaTech 2025 Innovation of the Year top 30 startups, as chosen by VivaTech in partnership with TechCrunch:

Chipiron: France, health
Virtuosis AI: Switzerland, information technologies
Enerdrape SA: Switzerland, energy
snap DISCOVERY: Germany, deep tech, BCI
NunoX Technologies: Taiwan, software development/cloud services
Phigi: France, industry
Noxon: Germany, health
.lumen: Romania, mobility/transportatio
HUA TEC International: Taiwan, health
Video Analytics for Safety: Singapore, information technologies
Geolinks Services: France, energy
Moonlite Labs: Canada, media/entertainment/culture
Stellaria: France, energy
Mendo: France, software development/cloud services
NeuralTeks: France, health
Vita325: Ukraine, health
Blue Skies Minerals GmbH: Canada, industry
Anivance AI: Taiwan, health
La Touche Musicale: France, media/entertainment/culture
InSimili: Italy, health
Nellow: France, information technologies
Oncoelectronics: France, health
Zeeh Africa: Nigeria, banking/finance/insurance/legal
LumiSync: France, telecom/connectivity
Onkos Molecular Diagnostics: Spain, health
Wisp Solutions: France, mobility/transportatio
Werover: United Kingdom, energy
BeyondMath: United Kingdom, information technologies
Kumulus: France, industry
FireTracking: New Caledonia, software development/cloud services

If you’re planning to be in Paris June 11-14, make sure to reserve your VivaTech pass today!

View original article on techcrunch.com

Most Recent

Amazon is taking its biggest shot at Nvidia yet with new TorchNeuron dev tool

Amazon wants to break Nvidia’s hold on PyTorch, the free toolkit used to build most AI apps, so that more developers run their apps on alternative chips like its own.

Oct 19, 2026

Replika’s founder built the AI assistant she pitched at Disrupt 12 years ago

Eugenia Kuyda's newest startup Wabi is positioned to take advantage of an idea she had more than a decade ago. Wabi offers a personal AI assistant with a twist, free and downloadable to anyone today.

Oct 19, 2026

AI assistant startup Town nabs unicorn valuation 4 months after launch

AI assistant startup Town nabbed a unicorn valuation on Monday, announcing a $108 million Series B round co-led by Forerunner Ventures and Menlo Ventures.

Oct 19, 2026

Khosla Ventures doubles down on Even Healthcare to challenge India’s hospital economics

Even Healthcare reaches a $300 million valuation in a Khosla Ventures-led round as it plans to expand its hospital network in India.

Oct 19, 2026

Similar Posts

TechCrunch and VivaTech partner for the VivaTech Innovation of the Year

TechCrunch is joining forces with VivaTech, Europe's biggest startup and tech event, to select startups for the prestigious VivaTech Innovation of the

May 16, 2025

Meet the finalists: VivaTech’s 5 most visionary startups of 2025

Narrowing down the 30 most visionary startups of the year to just five finalists was no easy feat. VivaTech's Innovation of the Year attracted an

Jun 6, 2025

The 2025 Startup Battlefield 200 is here — see who made the cut

We’re thrilled to unveil the 2025 Startup Battlefield 200 — TechCrunch’s handpicked list of the most promising early-stage startups.

Aug 27, 2025

The 2026 Startup Battlefield 200 is here — see who made the cut

We're thrilled to unveil the 2026 — TechCrunch's annual, handpicked list of the 200 most promising early-stage startups from around the world. These founders rose to the top from thousands of applications spanning every industry and geography. Their reward? A coveted spot to exhibit at TechCrunch Disrupt 2026, taking place October 13–15 in San Francisco's Moscone West.

Aug 20, 2026